- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03165552
An Educational Intervention to Prevent Acute Kidney Injury in Primary Care. The ED-AKI-P Implementation Study (ED-AKI-P)
24 de setembro de 2019 atualizado por: University of Leicester
Patients with abnormal kidney function are common in primary care, particularly in people with other long standing illnesses.
Some of these patients have long standing weakness of their kidneys, others develop new kidney weakness alongside other new illnesses.
Patients with weak kidneys are more likely to be admitted to hospital, spend longer in hospital or die than those with normal kidneys.
Although these events are common, how kidney weakness develops in the community is not well understood and awareness is poor.
It is known that appropriate attention to a patient's medical care at times of high risk may reduce the onset of new kidney weakness.
We have developed a new education package for primary healthcare professionals and patients.
This will teach them about risks of new kidney weakness in their patients, give advice about how to combat them, and help prevent it occurring.
This project will also use a new software tool - IMPAKT EVOLVE-AKI - to extract information from primary care systems and combine this with hospital data to identify developing kidney weakness much more accurately primary care .
Both these elements of the study have already been tested in primary care and we are confident that they work well.
Patients and the public have been involved in the development of these tools and will also be closely involved in their implementation.
We now intend to implement the education more widely in primary care.
We will then test how effectively the education has been implemented and whether it has a significant effect on the number of episodes of new kidney weakness developing in primary care.
We calculate that we will need to provide this education to 36 practices to be able to determine accurately whether the programme significantly reduces new kidney weakness.
Advice we have received from colleagues in primary care indicates that they are very interested in this education programme, and we believe that that a positive result from this study will lead to rapid and wide implementation of this combined programme of education and data analysis to the benefit of patients across the UK.
This study fits well with a national programme of work in this area, and this combination will help with wider adoption of the study findings when the results are available.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Descrição detalhada
Acute kidney injury (AKI) is a common cause of excess morbidity and mortality amongst patients with long term conditions, and is a common finding in patients admitted acutely into hospital.
Although the disease commonly develops in the community there is little evidence to guide identification of patients at risk or how best to educate healthcare workers in primary care to improve the care of patients at risk of AKI.
We hypothesise firstly that: an AKI educational intervention in primary care can be delivered to healthcare practitioners with high integrity, and secondly that: an AKI educational intervention delivered in primary care will result in a decreased incidence of AKI in the community.
To test this we will build on pilot work that detects high-AKI risk patients and provides education for healthcare workers and at-risk patients.
The study will bring together novel informatics, and education programme for primary healthcare workers along with patient information and guidance.
Recruitment will be at the practice level and will take place after the delivery of the face to face educational intervention.
Recruited practices will have their high risk AKI patients identified using web based software, and GPs will be encouraged, where clinically appropriate, to contact patients with an educational leaflet advising them how to prevent AKI by stopping medications under certain circumstances.
In addition a variety of associated biomedical data will be obtained from practice IT systems to identify the preceding incidence of AKI in any recruited practice.
Eighteen months after the delivery of the education intervention the incidence of AKI in each practice will again be determined to examine the effect of the educational intervention on AKI incidence.
The fidelity of delivery of the education intervention will also be studied using qualitative techniques.
Power calculations suggest that 36 practices will need to participate to detect a 25% reduction in AKI incidence.
We anticipate that this programme will effectively reduce AKI community incidence and will be of significant interest to commissioners.
Study findings will be disseminated through a variety of avenues including through structures established by NHS England to support improvements in AKI management.
Tipo de estudo
Intervencional
Inscrição (Real)
28
Estágio
- Não aplicável
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
18 anos e mais velhos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Não
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion criteria:
All patients aged over 18 registered with the practice
Exclusion criteria:
Patients under the age of 18
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Pesquisa de serviços de saúde
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Educational Arm
This group will receive an acute kidney injury educational intervention
|
A face to face, a constructivist learning approach to encourage users to explore and learn about the topic of AKI in a way that maximises educational value.
The programme is supported by a web based resource that presents a series of realistic case studies highlighting common causes of AKI in primary care designed to be easy to access and navigate, whilst being visual and interactive to enhance user engagement.
The educayion is delivered to healthcare staff not to patients.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Incidence of acute kidney injury before and after educational intervention
Prazo: 18 months
|
The incidence of AKI in a group of practices will be measured before and after an educational intervention
|
18 months
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
1 de novembro de 2015
Conclusão Primária (Real)
1 de outubro de 2018
Conclusão do estudo (Real)
1 de outubro de 2018
Datas de inscrição no estudo
Enviado pela primeira vez
23 de maio de 2017
Enviado pela primeira vez que atendeu aos critérios de CQ
23 de maio de 2017
Primeira postagem (Real)
24 de maio de 2017
Atualizações de registro de estudo
Última Atualização Postada (Real)
26 de setembro de 2019
Última atualização enviada que atendeu aos critérios de controle de qualidade
24 de setembro de 2019
Última verificação
1 de setembro de 2019
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 0524
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Lesão Renal Aguda
-
Zhen LiInscrevendo-se por conviteTransplante simultâneo de pâncreas-KidneyChina
-
Chung Shan Medical UniversityNational Science and Technology Council, TaiwanAinda não está recrutandoObesidade Diabetes Mellitus tipo 2 | Doença hepática esteatótica associada à disfunção metabólica | Síndrome cardiovascular-Kidney-metabólicaTaiwan
-
University Hospital, Basel, SwitzerlandAinda não está recrutandoSíndrome cardiovascular-Kidney-metabólica | Síndrome de Cradiovascular-Kidney-Metabolic (CKLM)Suíça
-
CHU de ReimsAinda não está recrutandoResponsabilidade do fluido no período de transplante pós-Kidney precoceFrança
-
Camille N. Kotton, MDKamada, Ltd.; University of Texas Southwestern Medical CenterRecrutamentoCitomegalovírus | Transplante de rim; Complicações | Transplante de órgão | Complicações de transplante de fígado | Transplante simultâneo de Kidney; ComplicaçõesEstados Unidos
-
Nanjing Medical UniversityAinda não está recrutandoSíndrome cardiovascular-Kidney-metabólica
-
First Affiliated Hospital of Fujian Medical UniversityRecrutamentoDoenças Metabólicas | Doença Renal Crônica | Doenças Cardiovasculares (DCV) | Síndrome cardiovascular-Kidney-metabólicaChina
-
Chung Shan Medical UniversityNational Science and Technology Council, TaiwanConcluídoDiabetes tipo 2 | Doenca renal | Obesidade e Sobrepeso | Fator de Risco de Doença Cardiovascular | Síndrome cardiovascular-Kidney-metabólica
-
University of Alabama at BirminghamOhio State University; American Heart Association; Tuskegee UniversityRecrutamentoDoenças cardiovasculares | Fumar | Hipertensão | Obesidade | Diabetes | Hiperlipidemia | Doenca renal | Síndrome cardiovascular-Kidney-metabólicaEstados Unidos
-
Shanghai Changzheng HospitalRecrutamentoHipertensão | Diabetes | Doenças da Tireoide | Síndrome metabólica | Dislipidemia | Distúrbio do Metabolismo Ósseo | Doença Renal Crônica (DRC) | Obesidade e Sobrepeso | Doenças Cardiovasculares (DCV) | Síndrome cardiovascular-Kidney-metabólicaChina